On Wednesday, August 21st, Pulse Canada hosted an expert panel workshop in Toronto on the potential for a health claim related to Lentils and Post-prandial Glycaemia in Toronto. Invited delegates to the workshop included over 30 representatives from the pulse industry, food industry, academia as well as and regulatory experts. The purpose of the workshop was to provide a forum in which to discuss a systematic literature review that was conducted in 2012 by Nutrasource Diagnostics Inc (NDI) with respect to achieving a health claim related to lentils and short term blood sugar control in Canada, the US or the EU.
Krista Coventry from NDI presented a background on the regulatory frameworks in Canada, the US, the EU and Australia/New Zealand.
FSSAI REGULATIONS FOR THE IMPORT, MANUFACTURE AND SALE OF NUTRACEUTICALS IN I...Swapnil Fernandes
- Nutraceutical market has shown steady increase in the last decade.
- The import, manufacture and marketing regulations for nutraceuticals in India have been streamlined with the updation of the FSSAI regulations 2016.
- RDA’s are a collection of values to express a person's nutrient need based on their life stage & gender.
- The RDA recommendations for the Indian population has been provided by the ICMR on the basis of scientific studies and subsequent data generated.
“EFSA lacks autonomy, it is subject to the lobbies.
Its mode of operation must be revised from top to bottom.”
JOSÉ BOVÉ
http://elproyectomatriz.wordpress.com/2011/06/14/efsa-agencia-europea-de-seguridad-alimentaria-%c2%bfseguridad/
Presentation by Ric Hobby, VP Regulatory, Government and Industry Affairs, Herbalife International at the International Life Sciences Institute Seminar in Taiwan, 2014
DIETARY SUPPLEMENT
The purpose of dietary supplements, is to enhance or supplement the diet. Even though a product is marketed as a dietary supplement, it is still considered a medicine to the extent that it is meant to treat, diagnose, cure, or prevent diseases.
Tablets, capsules, soft gels, powders, bars, gummies, and liquid supplements are just a few of the many different forms that supplements can take.
It is a product that is intended to supplement the diet that bears or contains one or more of the following dietary ingredients: a vitamin, a mineral, an herb or other botanical, an amino acid.
A dietary substance use by human to supplement the diet by increasing the total daily intake, or a concentrate, metabolite, constituent, extract, or combinations of these ingredients.
FDA Role
Companies can often introduce a dietary supplement to the market without notifying FDA.
FDA’s role in regulating dietary supplements primarily begins after products enter the marketplace.
If a product is found to be unsafe or not otherwise in compliance with the law, FDA can work with the company to bring the product into compliance or possibly remove it from the market.
FDA regulates both finished dietary supplement products and dietary ingredients.
FDA regulates dietary supplements under a different set of regulations than those covering "conventional" foods (edible fruits and vegetables) and drug products.
Role of DSHEA
Manufacturers and distributors of dietary supplements and dietary ingredients are prohibited from marketing products that are adulterated or misbranded.
That means that these firms are responsible for evaluating the safety and labelling of their products before marketing to ensure that they meet all the requirements of the Federal Food, Drug, and Cosmetic Act (FFDCA) as amended by DSHEA and FDA regulations.
FDA has the authority to take action against any adulterated or misbranded dietary supplement product after it reaches the market
The Dietary Supplement Health and Education Act of 1994 was enacted to prohibit
Dietary supplement manufacturers and distributors from making false claims (such as "natural" and "therapeutic," on supplement labels)
The law also prohibits the manufacture and sale of adulterated dietary supplements.
Aim of these act:
To make dietary supplements safer by forbidding manufacturers and distributors from producing and selling mislabelled or adulterated products.
Act requires that the manufacturer of the dietary supplement ensures their product meets DSHEA and FDA regulations.
Table of Contents
Short Title Reference Table Of Contents
Findings
Definitions
Safety of Dietary Supplements and Burden of Proof on FDA
Dietary Supplement Claims
Statements of Nutritional Support
Dietary supplement ingredient labeling and nutrition information labeling
New dietary ingredients
Good manufacturing practices
Conforming amendments
Withdrawal of the regulations and notice
Commission on dietary supplement labels
The recently enacted Food Safety Modernization Act is the greatest expansion of FDA’s food regulatory authority since the enactment in 1938 of the Federal Food, Drug, and Cosmetic Act. This presentation discuses the scope, impact and implementation of the Act. Presented by FDAImports.com Founder and CEO, Benjamin England.
For more on the Food Safety Modernization Act and how it affects companies, manufacturers and importers please visit:
http://www.fdaimports.com/FSMA
REGULATORY ASPECTS OF FOOD & NUTRACEUTICALS A GLOBALKapilKumar198
This presentation contains detailed information about the regulatory aspects of food and nutraceuticals a global prospective, which includes WHO guidelines on nutrition and NSF International.
GMP Guidelines for Nutraceuticals - Indian And EuropeanVarshaJindaniya
This GMP Guidance Document covers the entire manufacturing process of Health Supplements/ Nutraceuticals in the form of Powders, Tablets, Capsules, Soft Gel Capsules and Liquids starting from procurement of raw materials to despatch of finished product.
Contact me: www.linkedin.com/in/varsha-jindaniya
FSSAI REGULATIONS FOR THE IMPORT, MANUFACTURE AND SALE OF NUTRACEUTICALS IN I...Swapnil Fernandes
- Nutraceutical market has shown steady increase in the last decade.
- The import, manufacture and marketing regulations for nutraceuticals in India have been streamlined with the updation of the FSSAI regulations 2016.
- RDA’s are a collection of values to express a person's nutrient need based on their life stage & gender.
- The RDA recommendations for the Indian population has been provided by the ICMR on the basis of scientific studies and subsequent data generated.
“EFSA lacks autonomy, it is subject to the lobbies.
Its mode of operation must be revised from top to bottom.”
JOSÉ BOVÉ
http://elproyectomatriz.wordpress.com/2011/06/14/efsa-agencia-europea-de-seguridad-alimentaria-%c2%bfseguridad/
Presentation by Ric Hobby, VP Regulatory, Government and Industry Affairs, Herbalife International at the International Life Sciences Institute Seminar in Taiwan, 2014
DIETARY SUPPLEMENT
The purpose of dietary supplements, is to enhance or supplement the diet. Even though a product is marketed as a dietary supplement, it is still considered a medicine to the extent that it is meant to treat, diagnose, cure, or prevent diseases.
Tablets, capsules, soft gels, powders, bars, gummies, and liquid supplements are just a few of the many different forms that supplements can take.
It is a product that is intended to supplement the diet that bears or contains one or more of the following dietary ingredients: a vitamin, a mineral, an herb or other botanical, an amino acid.
A dietary substance use by human to supplement the diet by increasing the total daily intake, or a concentrate, metabolite, constituent, extract, or combinations of these ingredients.
FDA Role
Companies can often introduce a dietary supplement to the market without notifying FDA.
FDA’s role in regulating dietary supplements primarily begins after products enter the marketplace.
If a product is found to be unsafe or not otherwise in compliance with the law, FDA can work with the company to bring the product into compliance or possibly remove it from the market.
FDA regulates both finished dietary supplement products and dietary ingredients.
FDA regulates dietary supplements under a different set of regulations than those covering "conventional" foods (edible fruits and vegetables) and drug products.
Role of DSHEA
Manufacturers and distributors of dietary supplements and dietary ingredients are prohibited from marketing products that are adulterated or misbranded.
That means that these firms are responsible for evaluating the safety and labelling of their products before marketing to ensure that they meet all the requirements of the Federal Food, Drug, and Cosmetic Act (FFDCA) as amended by DSHEA and FDA regulations.
FDA has the authority to take action against any adulterated or misbranded dietary supplement product after it reaches the market
The Dietary Supplement Health and Education Act of 1994 was enacted to prohibit
Dietary supplement manufacturers and distributors from making false claims (such as "natural" and "therapeutic," on supplement labels)
The law also prohibits the manufacture and sale of adulterated dietary supplements.
Aim of these act:
To make dietary supplements safer by forbidding manufacturers and distributors from producing and selling mislabelled or adulterated products.
Act requires that the manufacturer of the dietary supplement ensures their product meets DSHEA and FDA regulations.
Table of Contents
Short Title Reference Table Of Contents
Findings
Definitions
Safety of Dietary Supplements and Burden of Proof on FDA
Dietary Supplement Claims
Statements of Nutritional Support
Dietary supplement ingredient labeling and nutrition information labeling
New dietary ingredients
Good manufacturing practices
Conforming amendments
Withdrawal of the regulations and notice
Commission on dietary supplement labels
The recently enacted Food Safety Modernization Act is the greatest expansion of FDA’s food regulatory authority since the enactment in 1938 of the Federal Food, Drug, and Cosmetic Act. This presentation discuses the scope, impact and implementation of the Act. Presented by FDAImports.com Founder and CEO, Benjamin England.
For more on the Food Safety Modernization Act and how it affects companies, manufacturers and importers please visit:
http://www.fdaimports.com/FSMA
REGULATORY ASPECTS OF FOOD & NUTRACEUTICALS A GLOBALKapilKumar198
This presentation contains detailed information about the regulatory aspects of food and nutraceuticals a global prospective, which includes WHO guidelines on nutrition and NSF International.
GMP Guidelines for Nutraceuticals - Indian And EuropeanVarshaJindaniya
This GMP Guidance Document covers the entire manufacturing process of Health Supplements/ Nutraceuticals in the form of Powders, Tablets, Capsules, Soft Gel Capsules and Liquids starting from procurement of raw materials to despatch of finished product.
Contact me: www.linkedin.com/in/varsha-jindaniya
Food Safety Modernization Act (FSMA) regulatory requirements by FDABrian Thomas
Food Safety Modernization Act (FSMA) is placing new regulatory demands on food manufacturers and suppliers in the US market. For the first time, FDA has a legislative mandate to require comprehensive, prevention-based controls across the food supply. As key implementation deadlines approach, food manufacturers are shifting from a reactionary to a preventive footing, with stricter controls, documentation, and supplier verification requirements. This means there is a new regulatory world for food producers, including regulations for food-borne illness prevention and traceability. Presentation provides a summary of the new regulations, the risks and challenges faced by food producers, and the opportunities to take action through applications of modern control and information technology.
EU Food Regulation on Additives, Novel Foods and Food Contact MaterialsDaniele Pisanello
The presentation has been used within the EIPA's Seminar "Introduction to the fundamentals of EU Food Law: principles, procedures & main regulatory components", 7 and 13 of Luly 2016, on behalf of European Commission, DG Translation.
It provides an introduction to specific legal standards relating to food additives, novel foods and food contact materials.
The Food Safety Modernization Act (FSMA), signed into law on Jan. 4, 2011, expands the power of the Food and Drug Administration (FDA) to oversee food safety with a focus on prevention. Each year, about 48 million people get sick, 128,000 are hospitalized and 3,000 die—all from foodborne diseases that are preventable.
The FSMA is designed to reduce those numbers by radically updating industry practices to ensure food safety and defense in an evolving global economy. Because of how vast and interconnected food supply has become, these regulations will impact a number of industries.
Presented by A.K. Singla to the ILRI workshop on safety of animal source foods with an emphasis on the informal sectors, New Delhi, India, 8 February 2011
The regulations of the Codex refer to food hygiene and quality, including microbiological standards, food additives, pesticides and residues from veterinary drugs, contaminants, food labeling and marketing, methods for sampling and hazard analysis, food import and export, certification system, etc.
Medicinal products are highly regulated in the European Union (EU) and are subject to a separate, complicated system of approvals that governs how, when, where, and in what form such products will be allowed to be sold within the borders of the EU.
Pharmaceutical regulatory systems in the EU comprise a decentralized body called the European Medicines Agency (EMA), Heads of Medicines Agencies (HMA), National Competent Authorities (NCAs) and European Directorate for the Quality of Medicines (EDQM). and collection of rules and regulations governing medicinal products in the EU is Eudralex.
The European Medicines Evaluation Agency (EMEA) was established in London, in the year 1995, to coordinate the European Union (EU) member states for evaluating and controlling the medicinal products for both human and veterinary use
The European medicines regulatory system is based on a network of around 50 regulatory authorities from the 31 EEA countries (28 EU Member States plus Iceland, Liechtenstein and Norway)
EMA is responsible for the scientific evaluation, essentially of innovative and high-technology medicines developed by pharmaceutical companies for use in the EU.
EMA has various committees for various categories of medicinal products
Committee for Medicinal Products for Human Use (CHMP)
Pharmacovigilance Risk Assessment Committee (PRAC)
Committee for Medicinal Products for Veterinary Use (CMVP)
Committee for Orphan Medicinal Products (COMP)
Committee on Herbal Medicinal Products (HMPC)
Committee for Advanced Therapies (CAT)
Paediatric Committee (PDCO)
For a medicinal product to seek market authorization in Europe, the manufacturer or sponsor shall choose a pathway from four different pathways based upon the type of medicinal substance, and requirements such as a number of countries chosen for marketing, timeline, etc.
Food Safety Modernization Act (FSMA) regulatory requirements by FDABrian Thomas
Food Safety Modernization Act (FSMA) is placing new regulatory demands on food manufacturers and suppliers in the US market. For the first time, FDA has a legislative mandate to require comprehensive, prevention-based controls across the food supply. As key implementation deadlines approach, food manufacturers are shifting from a reactionary to a preventive footing, with stricter controls, documentation, and supplier verification requirements. This means there is a new regulatory world for food producers, including regulations for food-borne illness prevention and traceability. Presentation provides a summary of the new regulations, the risks and challenges faced by food producers, and the opportunities to take action through applications of modern control and information technology.
EU Food Regulation on Additives, Novel Foods and Food Contact MaterialsDaniele Pisanello
The presentation has been used within the EIPA's Seminar "Introduction to the fundamentals of EU Food Law: principles, procedures & main regulatory components", 7 and 13 of Luly 2016, on behalf of European Commission, DG Translation.
It provides an introduction to specific legal standards relating to food additives, novel foods and food contact materials.
The Food Safety Modernization Act (FSMA), signed into law on Jan. 4, 2011, expands the power of the Food and Drug Administration (FDA) to oversee food safety with a focus on prevention. Each year, about 48 million people get sick, 128,000 are hospitalized and 3,000 die—all from foodborne diseases that are preventable.
The FSMA is designed to reduce those numbers by radically updating industry practices to ensure food safety and defense in an evolving global economy. Because of how vast and interconnected food supply has become, these regulations will impact a number of industries.
Presented by A.K. Singla to the ILRI workshop on safety of animal source foods with an emphasis on the informal sectors, New Delhi, India, 8 February 2011
The regulations of the Codex refer to food hygiene and quality, including microbiological standards, food additives, pesticides and residues from veterinary drugs, contaminants, food labeling and marketing, methods for sampling and hazard analysis, food import and export, certification system, etc.
Medicinal products are highly regulated in the European Union (EU) and are subject to a separate, complicated system of approvals that governs how, when, where, and in what form such products will be allowed to be sold within the borders of the EU.
Pharmaceutical regulatory systems in the EU comprise a decentralized body called the European Medicines Agency (EMA), Heads of Medicines Agencies (HMA), National Competent Authorities (NCAs) and European Directorate for the Quality of Medicines (EDQM). and collection of rules and regulations governing medicinal products in the EU is Eudralex.
The European Medicines Evaluation Agency (EMEA) was established in London, in the year 1995, to coordinate the European Union (EU) member states for evaluating and controlling the medicinal products for both human and veterinary use
The European medicines regulatory system is based on a network of around 50 regulatory authorities from the 31 EEA countries (28 EU Member States plus Iceland, Liechtenstein and Norway)
EMA is responsible for the scientific evaluation, essentially of innovative and high-technology medicines developed by pharmaceutical companies for use in the EU.
EMA has various committees for various categories of medicinal products
Committee for Medicinal Products for Human Use (CHMP)
Pharmacovigilance Risk Assessment Committee (PRAC)
Committee for Medicinal Products for Veterinary Use (CMVP)
Committee for Orphan Medicinal Products (COMP)
Committee on Herbal Medicinal Products (HMPC)
Committee for Advanced Therapies (CAT)
Paediatric Committee (PDCO)
For a medicinal product to seek market authorization in Europe, the manufacturer or sponsor shall choose a pathway from four different pathways based upon the type of medicinal substance, and requirements such as a number of countries chosen for marketing, timeline, etc.
Health claim dossier: opportunities for SMEs and lessons learnt by Alfonso Si...Yohan Lecuona
TeRiFiQ Conference
Reducing salt, fat and sugar in everyday foods – Results from TeRiFiQ EU project and opportunities for food industry
27 October 2015 ♦ Milan EXPO, Italy
In Spring 2013, we are on the precipice of dramatic, disruptive change in the health field that offers an unprecedented opportunity and challenge to transform health care and population health.
We know that traditional public health approaches along with more and better health care are not enough to improve health outcomes, equity, and cost. We must also:
- implement sustainable, fundamental "upstream" changes that address the root causes of disease and disability; and
- transform the way we deliver health care to ensure access to quality, affordable health care for all.
Enjoy this Bright Spot presentation from Lucia Sayre of Health Care Without Harm, which was presented at the 2013 Annual Leadership Conference, co-sponsored by the Center for Health Leadership (CHL) and the California Pacific Public Health Training Center (CALPACT) at UC Berkeley's School of Public Health.
To learn more about this event, please visit:
http://calpact.org/index.php/en/events/leadership-conference
Learn more about CALPACT:
http://calpact.org/
Learn more about the CHL:
http://chl.berkeley.edu/
Updates on Nutrition Labeling and Claims Regulations in Thailand by Tipvon Parinyasiri, Director of Bureau of Food, Thai Food and Drug Administration.
Presented at the 9th Seminar on Nutrition Labeling, Claims and Communication Strategies, August 4 ~ 5 August, Manila, Philippines.
Updates on Nutrition Labeling and Claims Regulations in Malaysia by Norrani Eksan, Food Safety and Quality Division, Ministry of Health Malaysia
Presented at the 9th Seminar on Nutrition Labeling, Claims and Communication Strategies, August 4 ~ 5 August, Manila, Philippines.
Anlässlich des 10-jährigen Bestehens der AGES und der 5-jährigen Kooperation mit dem deutschen Bundesinstitut für Risikobewertung (BfR) fanden zwei Spezialveranstaltungen zum Thema Nahrungsergänzungsmittel (NEM) statt, bei der die bisher umfassendste Erhebung zum Thema im deutschen Sprachraum exklusiv präsentiert wurde. Risiken und Nutzen von NEM wurden aus Sicht der Lebensmittel- & Arzneimittelsicherheit, Risikobewertung & Risikokommunikation, die den Verbraucherinteressen gerecht wird, betrachtet. Anbei die Dokumentation der beiden Fachtagungen mit den Vorträgen und Präsentationen:
1. AGES-BfR-Forum "Nahrungsergänzungsmittel: Nutzen und Risiko", 30. Mai 2012 (AGES, Wien)
http://www.ages.at/ages/ages-akademie/stakeholderveranstaltungen/wien-nahrungsergaenzungsmittel/
14. BfR-Forum Verbraucherschutz Nahrungsergänzungsmittel "Notwendig, Luxus oder gesundheitliches Risiko?", 10./11. Oktober 2012 (BfR, Berlin)
http://www.bfr.bund.de/de/veranstaltung/14__bfr_forum_verbraucherschutz__nahrungsergaenzungsmittel_-129397.html
Here you will find an introduction to the course which I have already used in class. Please take note of the topics and start considering the one(s) that you will be working on.
This is concise comparative analysis of health food drinks in India. The deck contains briefs on health food and Health food drinks followed by analysis of major HFD Brands in India and their marketing approaches. The deck concludes with challenges, opportunities and key success factors in the Indian Health Food drinks Industry.
Bringing Your Supplements, Medical Foods and Pharmaceutical Drugs to MarketNutrcapnetwork
With companies in nutrition and health & wellness making crucial product development and marketing decisions, a clear picture of regulatory tracks for supplements, medical foods and drugs is essential. Co-hosted by Nutritional Capital Network and Todd Harrison, Co-Chair, Food, Dietary Supplements and Cosmetics Practice of Venable LLP, NCN's law firm sponsor.
Guideline của FDA cung cấp câu trả lời về những câu hỏi thường gặp về thực phẩm y tế như: Thực phẩm y tế là gì? Thực phẩm y tế có phải thuốc không? Quy định ghi nhãn như thế nào?
Xem thêm các tài liệu khác trên kênh của Công ty Cổ phần Tư vấn thiết kế GMP EU.
Submitting a food product to obtain a health claim is a very complex process.
Institut Kurz is specialized in preparation of dossiers for Health Claim applications according to EU-Ordinance 1924.
If you want your food product to have a health claim, Institut Kurz does it for you.
Contact us: info@institut-kurz.com
www.institut-kurz.com
ADA submitted comments on two proposed rules from the FDA modifying the Nutrition Facts label that appears on most packaged foods in the United States and gives consumers information on the nutritional content of the food. The FDA is proposing changes to the content and layout of the Nutrition Facts label.
Substantiating health claims - Food Australia April 2016Andreas Kahl
In this Food Australia article, Dr Malcolm Riley and Dr Welma Stonehouse take a look at substantiating health
and related claims for food and beverage products.
3.the status of functional foods in taiwan 0917Peerasak C.
Facebook LIVE : “Future food when the world changes. What’s the next step of Thailand? ” (Intelligent Future Food Project supported by Ministry of Industry) ... 21 September 2018, At Kamolthip Venue, The Sukosol Hotel, Bangkok.
1. Presentation1_Status of Functional Food in Japan_Ornanong-NFI
2. Griffith, morning slide, NFI, 18092018
3.The Status of Functional Foods in Taiwan 0917
4. Presentation2_Do_Donot health claim in Japan_Ornanong-NFI
5.Do and Don’t in Taiwan Health Claims 0910
6. Griffith, afternoon slide, NFI, 18092018
This will compare and demystify basis for health claims on food products as prescribed by the United States Code of Federal Regulations (CFR) Title 21 Section 101.14 and the equivalent Indian regulation, ‘Food Safety and Standards (Claims and Advertisement) Regulations, 2018’. Part I focused on the basis for health claims and concluded with food-health relationships – calcium and vitamin D with osteoporosis.
Comparative analysis of food for special medical purpose for infants regulati...REACH24H Consulting Group
The presentation is to explain in detail China GB 25596-2010 General Standard for Infant Formula for Special Medical Purposes, give insights into the meaning and purpose of the regulation that becomes effective 1 October 2015. The webinar also aims to compare the similarities and differences to EU and US regulations including registration requirements and labeling on foods for medical purposes intended for infants.
Analyzing the Dietary Supplement Health and Education Act and other related r...AJHSSR Journal
The research introduces the policy of Dietary Supplement Health and Education Act (DSHEA) and relevant regulations and backgrounds with quantitative data analysis. Studying case studies of Dietary Supplement Health Educational Act (DSHEA) might address Food and Drug Administration (FDA) accountabilities and improvements.
The benefits and risks associated with functional foods and nutraceuticals are presented in the presentation. Also, way-forward is captured in light of the risks.
This series compares and demystifies basis for health claims on food products as prescribed by the United States Code of Federal Regulations (CFR) Title 21 Section 101.14 and the equivalent Indian regulation, ‘Food Safety and Standards (Claims and Advertisement) Regulations, 2018’. Part I focused on the basis for health claims and concluded with food-health relationships – calcium and vitamin D with osteoporosis. Part II discussed the relationships between Fat and Cancer, Sodium and Hypertension and Saturated Fat, Cholesterol and Heart Disease. Part III discussed the relationships between Potassium, Blood Pressure and Stroke and also touched upon some of the unique nutrient-health relationships stipulated in the FDA regulation.
Founded by Dr. Robert S. McQuate and Dr. Richard C. Kraska, two seasoned regulatory veterans with over 60 years’ collective experience working for and with the FDA, GRAS Associates provides customized food safety and compliance regulatory consulting solutions for products regulated by the U.S. Food and Drug Administration (FDA), including products which may be considered to be Generally Recognized as Safe (GRAS).
Diteba is a global leader in complex analytical and bioanalytical testing, providing solutions and services to the pharmaceutical, biopharmaceutical and nutraceutical industries.
We support both large and small molecule testing for various dosage forms including solids, semi-solids, liquids, aerosols and other special dosage forms. Our work is focused in several core areas including: In Vitro Release Rate Testing (IVRT) services; stability storage and testing; method development and validation and QC testing at our fully accredited facility.
In this presentation, you'll learn more about Nutrasource, a contract research organization and consulting from that provides a vertically integrated, virtual R&D consulting service platform for the entire consumer health products industry.
The Value of Product-Specific Data for Marketing and Sales ROINutrasource
As regulatory requirements for foods and health products tighten across the world and product categories become increasingly competitive, more companies than ever are investing in research and development (R&D) to help their products stay novel, comply with regulations and stand out in the marketplace. Product-specific data is the common and trending theme that meets these objectives. In order to generate this data successfully and within budget, companies must ensure they are maximizing their return on investment (ROI) as it relates to product sales and marketing. This lecture will provide you with valuable information about the value of product-specific data for marketing and sales, and discuss specific strategies your company can use to maximize your return on this investment.
Novel Approaches to Omega-3 Stability Testing Nutrasource
In the last decade, nutritional oil products such as omega-3s have grown to a multi-billion dollar industry globally. As a result, new analytical testing challenges have arisen from the current trend toward producing more attractive and more appetizing products created for a wider consumer base.
In formulating these "new and improved," better looking and better tasting products, different color and flavor additives are used, which can interfere with the most popular analytical procedure for determining the secondary oxidation of nutritional oil products, the p-anisidine value test.
In order to overcome these analytical challenges, a new alternative method for testing these additive-laden products has been established and is ready for use in this fast growing marketing segment.
Dr. Steven Li provides details about the latest innovation in omega-3 testing and its application in the omega-3 industry, at GOED Exchange 2014.
The International Fish Oil Standards (IFOS) Program: An OverviewNutrasource
The International Fish Oil Standards (IFOS) Program is the only third party testing and certification program for the fish oil industry. We help companies add market value to their brands so that they stand out on the shelf as symbols of purity, safety and stability. www.ifosprogram.com
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
3. Generally speaking, a food health claim is
considered to be “any representation in labelling
and advertising that states, suggests or implies
that a relation exists between the consumption of
foods or food constituents and health”
Codex Alimentarius Commission, 2004
REGULATORY DEFINITION:
HEALTH CLAIM
6. • Foods, as well as claims related to
health that appear on packaging
or in advertising of foods
in Canada, must comply with:
The Consumer Packaging and
Labelling Act (1971)
the Food and Drugs Act (1985)
the Food and Drug Regulations
REGULATORY FRAMEWORK (CANADA)
REGULATIONS
9. • No specific regulations governing use;
• No standardized nutritional criteria required;
• Do not refer to a specific health effect, disease,
or health condition;
• Can promote choosing a food for overall health
or promote healthy eating;
• Can provide dietary guidance, such as:
“Healthy for you...”
“Healthy choice...”
FOOD HEALTH CLAIMS (CANADA)
GENERAL HEALTH CLAIMS
10. • Function claims refer to the
maintenance and/or support of
body functions associated with the
maintenance of good health or
performance
FOOD HEALTH CLAIMS (CANADA)
FUNCTION HEALTH CLAIMS
“Coarse wheat bran helps to promote regularity.”
11. • Link consumption of food or food
constituents to a reduced risk of developing
a diet-related disease or condition in the
context of the total diet.
FOOD HEALTH CLAIMS (CANADA)
DISEASE-RISK REDUCTION CLAIMS
12. Sodium, potassium and hypertension
Calcium, vitamin D and osteoporosis
Saturated and trans fat and heart disease
Vegetables, fruit and some cancers
Non-fermentable carbohydrates and
dental caries
REGULATORY FRAMEWORK (CANADA)
APPROVED DISEASE/RISK-REDUCTION CLAIMS
13.
14. Enable consumers to easily recognize the
health benefit of a food
Claims about the treatment or mitigation
of a health-related disease or condition,
or about restoring, correcting or
modifying body functions;
Include a dose per serving of the food and
daily dose
FOOD HEALTH CLAIMS (CANADA)
DISEASE RISK-REDUCTION CLAIMS
THERAPEUTIC CLAIMS
15. Psyllium fibre and Blood cholesterol
Lowering
Plant sterols and Blood cholesterol Lowering
Oat fibre and blood cholesterol lowering
Unsaturated fats and Blood Cholesterol
Lowering
Barley Products and Blood Cholesterol
Lowering
REGULATORY FRAMEWORK (CANADA)
APPROVED THERAPEUTIC CLAIMS
17. REGULATORY FRAMEWORK: FOODS
ROLE OF THE GOVERNMENT
U.S. Food Authorities / Regulatory Bodies:
Food and Drug Administration [FDA]
• Center for Food Safety and Applied
Nutrition [CFSAN]
U.S. Department of Agriculture [USDA]
Federal Trade Commission [FTC]
19. FOOD HEALTH CLAIMS
APPROVED HEALTH CLAIMS
Soluble fiber from certain foods
and risk of Coronary Heart Disease
(21 CFR 101.81)
Plant Sterol/stanol esters
and risk of Coronary Heart Disease
(21 CFR 101.83)
Soy Protein
and risk of Coronary Heart Disease
(21 CFR 101.82)
20. HEALTH
CLAIMS
Nutrition Labelling & Education Act
[NLEA]
Authorized Health Claims
(1990 )
Food and Drug Administration
Modernization Act
[FDAMA]
Authorized Health Claims
(1997)
Qualified Health Claims
(2003)
FOOD HEALTH CLAIMS
HEALTH CLAIMS
21. FOOD HEALTH CLAIMS
NLEA AUTHORIZED HEALTH CLAIMS
The SSA Standard :
The Continuum of Scientific Discovery
• Confidence must exist in the validity of the substance-
disease relationship;
• Consensus between qualified experts that the claim is true
and valid;
• It should be unlikely that future studies or new data will
oppose the relationship;
• Overall, there needs to be a body of consistent, relevant
evidence.
Emerging
Evidence
Consensus
22. FOOD HEALTH CLAIMS
FDAMA AUTHORIZED HEALTH CLAIMS
• Health claims based on current, published,
authoritative statements from a credible
scientific body of the U.S.A ;
• Scientific evidence for the claim is considered
to have met the SSA standard;
• Submission of claim at least 120 days prior to
first use in interstate commerce; FDA will
review and notify the petitioner of the
outcome of compliance ruling.
23. FOOD HEALTH CLAIMS
QUALIFIED HEALTH CLAIMS
Based on FDA guidance documents (not legislation);
Claims are based on emerging science;
Evidence is not well-established;
The SSA standard cannot be met; therefore the FDA
cannot issue an authorizing regulation. Instead a
“letter of enforcement” or “letter of denial” is issued.
Qualifying language is used to illustrate the level of
scientific support
25. REGULATORY FRAMEWORK: FOODS (EU)
ROLE OF THE GOVERNMENT
EUROPEAN
COMMISSION
EUROPEAN
PARLIAMENT
EU
MEMBER STATES
EUROPEAN FOOD SAFETY
AUTHORITY (EFSA)
EXECUTIVE DIRECTOR
SCIENTIFIC EVALUATION
OF REGULATED PRODUCTS
DIRECTORATE
APPLICATIONS DESK FEED
PESTICIDES NUTRITION
GMO FOOD INGREDIENTS & PACKAGING
27. • When consideration a food health claim
evaluation, EFSA will consider:
If the food and/or food constituent is
defined and characterized;
If the claimed effect is defined and is
a beneficial physiological effect;
If a cause and effect relationship is
established between the
consumption of the food/constituent
and the claimed effect
REGULATORY FRAMEWORK (EU)
EVALUATION OF CLAIMS (EFSA)
28. • The food or substance must be sufficiently
characterized in relation to the claimed
effect (compared to reference food)
• Replacement Effect: evidence which
demonstrates the ‘replacement’ food (ie/
sweetener) has no effect on postprandial [PP]
glucose or insulin as compared to the
reference food (which would blood glucose)
• Independent or Comparative Effect: evidence
to demonstrate a significant in PPG, and a
significant in insulin or no change in insulin
REGULATORY FRAMEWORK (EU)
EVIDENCE REQUIREMENTS (PPG)
29. DIETARY FIBRE
“Consumption of arabinoxylan contributes to a reduction
of the glucose rise after a meal”.
SWEETENERS
“Consumption of foods/drinks containing xylitol instead
of sugar induces a lower blood glucose rise after meals
compared to sugar-containing foods/drinks”.
FRUCTOSE
“Consumption of fructose leads to a lower blood glucose
rise than consumption of sucrose or glucose”
FOOD HEALTH CLAIMS
APPROVED GENERAL FUNCTION CLAIMS
31. NUTRITION
CONTENT
CLAIMS
PART 3 DIVISION 1
SCHEDULE 1
HEALTH
CLAIMS
HIGH LEVEL
HEALTH CLAIMS
PART 3 DIVISION 2
SCHEDULE 2
GENERAL LEVEL
HEALTH CLAIMS
PART 3 DIVISION 2
SCHEDULE 3
PART 3 DIVISION 2
SELF-
SUBSTANTIATED
REGULATORY FRAMEWORK (A&NZ)
FOOD HEALTH CLAIM CATEGORIES
32. General claims:
• The food meets the Nutrient Profiling Scoring Criterion,
unless the food is standardized by Part 2.9 of the Code;
and
• The claim or the nutrition information panel under
Standard 1.2.8 includes the numerical value of the
Glycemic Index of the food
Specific claims:
• LOW: Glycemic Index ≤ 55
• MEDIUM: Glycemic Index of 56-69
• HIGH: Glycemic Index ≥ 70
REGULATORY FRAMEWORK (A&NZ)
GLYCEMIC INDEX CLAIMS
33. General claims:
• The food meets the Nutrient Profiling
Scoring Criterion, unless the food is a
food standardized by Part 2.9 of the
Code
• Descriptors of ‘low’, ‘medium’, and
‘high’ cannot be used in relation to
Glycemic Load claims, however,
numbers of the measure can be used,
e.g. Glycemic Load =30
REGULATORY FRAMEWORK (A&NZ)
GLYCEMIC LOAD CLAIMS
34.
35. JURISDICTION
NUTRIENT
CLAIMS
HEALTH CLAIMS
GENERAL LEVEL CLAIMS HIGH LEVEL CLAIM
CANADA
Nutrient
Content Claims
General Health Claims
Function Claims
Therapeutic Claims
Disease Risk Reduction Claims
USA
Nutrient
Content Claims
Structure/Function Claims
SSA Health Claims
Qualified Health Claims
EUROPE
Nutrition
Claims
General Function Claims Disease Risk Reduction Claims
AUSTRALIA
NEW ZEALAND
Nutrition Content
Claims
General Level Health Claims High Level Health Claims
REGULATORY FRAMEWORK (SUMMARY)
FOOD HEALTH CLAIM CATEGORIES